Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q1 FY23 results · Apr–Jun 2022
Caplin Point Laboratories reported revenue from operations of ₹346.33 crore (up 15.3% from Q1 FY22) and net profit of ₹86.31 crore (up 20.7% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 346.33 | 300.44 | +15.3% | 339.24 | +2.1% |
| Other income | 13.94 | 9.21 | +51.4% | 11.51 | +21.1% |
| Total income | 360.27 | 309.65 | +16.3% | 350.75 | +2.7% |
| Profit before tax | 105.09 | 89.52 | +17.4% | 99.92 | +5.2% |
| Net profit for the period | 86.31 | 71.53 | +20.7% | 80.83 | +6.8% |
| Attributable to shareholders of the company | 84.99 | 70.85 | +20.0% | — | — |
| EPS, basic (₹) | 11.21 | 9.37 | +19.6% | 10.43 | +7.5% |
| Net margin (%) | 24.9 | 23.8 | 23.8 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 116.39 | 127.50 | −8.7% | 111.94 | +4.0% |
| Other income | 34.97 | 19.33 | +80.9% | 10.26 | +240.8% |
| Total income | 151.36 | 146.83 | +3.1% | 122.20 | +23.9% |
| Profit before tax | 74.70 | 69.41 | +7.6% | 41.70 | +79.1% |
| Net profit for the period | 63.24 | 54.55 | +15.9% | 29.02 | +117.9% |
| EPS, basic (₹) | 8.34 | 7.21 | +15.7% | 3.83 | +117.8% |
| Net margin (%) | 54.3 | 42.8 | 25.9 |
Consolidated
- Filed with BSE
- 08 Aug 2022, 12:07 IST
- Board meeting
- 05 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Aug 2022, 12:07 IST
- Board meeting
- 05 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE